ZDZaiquan Dong

Zaiquan Dong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zaiquan Dong has a total of 99 co-authors. Here are the top co-authors by number of shared publications:

  • Qinglian Xie

    Department of Outpatient, West China Hospital of Sichuan University

    9 shared publications
  • Yanling Yuan

    Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, People’s Republic of China

    7 shared publications
  • Qiang Peng

    State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases West China Hospital of Stomatology Sichuan University Chengdu China

    5 shared publications
  • Xuan Guan

    Chengdu Medical College, Chengdu, People’s Republic of China

    5 shared publications
  • Jian Jiao

    Affiliation Sleep Medicine Center, Mental Health Center, Translational Neuroscience Center, West China Hospital, Sichuan University, Chengdu, P.R. China

    4 shared publications
  • Dongru Du

    West China School of Medicine, Sichuan University

    3 shared publications

Latest Publications

  • Open Access

    Community management: An effective model to reduce medication discontinuation rate in patients with schizophrenia

    by Hua Ren, Qin Yang, Changjiu He, Jian Jiao, Zaiquan Dong

    Background: Medication discontinuation is highly prevalent among patients with schizophrenia and is associated with poor clinical outcomes. Although community-based management models have been implemented in China to support patients, recent evidence of their effectiveness in reducing medication discontinuation rates remains limited. Methods: In this cross-sectional study, we surveyed 1,531 patients with schizophrenia under community management in Chengdu, China, using a multi-stage sampling approach. Data on treatment discontinuation (defined as cessation of all antipsychotics for >15 days without medical advice), socio-demographics, clinical characteristics, and service utilization were collected via face-to-face interviews. Univariate and multivariable logistic regression analyses were used to identify the factors associated with medication discontinuation. Results: The overall rate of medication discontinuation was 4.1%. Multivariable analysis identified several independent risk factors for discontinuation: weak stable disease state (adjusted odds ratio [aOR] = 2.70, 95% confidence interval [CI]: 1.34–5.24), lack of insight (aOR for partial vs. no insight = 0.25, 95% CI: 0.08–0.80; aOR for full vs. no insight = 0.18, 95% CI: 0.05–0.65), presence of noticeable side effects (aOR = 1.98, 95% CI: 1.05–3.64), and absence of regular follow-up (aOR for intermittent vs. no follow-up = 0.38, 95% CI: 0.20–0.72; aOR for regular vs. no follow-up = 0.22, 95% CI: 0.10–0.44). Conclusion: Community management was associated with a low rate of medication discontinuation in patients with schizophrenia. Key modifiable factors, including disease stability, insight, medication side effects, and follow-up adherence should be prioritized in community-based interventions to further improve treatment continuity.

  • Open Access

    Gut microbiota, circadian rhythms and their interactions: implications for the pathogenesis and treatment of depression

    by Dongru Du, Yanling Yuan, Xuan Guan, Qinglian Xie, Xueli Sun, Zaiquan Dong

    Depression is a complex and widespread mental illness that remains poorly understood in terms of pathogenesis and treatment. Recent research has highlighted the intricate connections between gut microbiota and circadian rhythms and indicated that they may serve as significant factors associated with depression. The gut microbiota and its metabolites may affect circadian rhythms via microbial oscillations, neurotransmitters, vagus nerve, epigenetic modifications and immune regulation, whereas the circadian rhythms may affect the gut microbiota via circadian gene expression, neurotransmitters, vagus nerve and immune regulation. These findings may provide new perspectives on the pathogenesis of depression and have led to the development of novel treatments targeting the gut microbiota, circadian rhythms and their interactions. This review explores how disturbances in the gut microbiota and circadian rhythms may contribute to depression and discusses the innovative treatments that have resulted from this knowledge. By focusing on this emerging area of study, this review reveals promising new developments in the pathogenesis and treatment of depression, emphasizing the novel concept that balancing our internal microbiome and body clock could be key to effectively managing this condition.


  • Open Access

    Development and validation of a probability-assessment nomogram for non-suicidal self-injury in hospitalized adolescents and young adults with mental disorders

    by Qi Liu, Yanjuan Ren, Yalin Huang, Ruyi Xie, Yinyuan Li, Zaiquan Dong, Xiaoxia Zhang

    Assessing non-suicidal self-injury (NSSI) in adolescents and young adults is a critical yet challenging aspect of psychiatric evaluations for hospitalized patients. This study aimed to develop a detective model for probability of NSSI in adolescents and young adults utilizing a retrospective cross-sectional analysis. Data from 658 hospitalized adolescents and young adults, including demographic characteristics, hormone levels, and violence risk factors, were collected. Age, history of suicide attempts, gender, and psychiatric diagnosis were identified as key detectors through Boruta and LASSO machine learning algorithms, leading to the construction of a nomogram. Model performance was evaluated based on discrimination, calibration, and decision curve analysis (DCA). The model achieved the area under the receiver operating characteristic curve (AUC) values of 0.803 (training set; 95% CI 0.763–0.843) and 0.745 (validation set; 95% CI 0.676–0.814). Calibration plots demonstrated strong alignment between predicted and actual outcomes. The Hosmer-Lemeshow test indicated good model fit, while DCA revealed clinically relevant threshold ranges for the training and validation sets, highlighting the model’s potential to inform clinical decision-making. This detective model can support the rational allocation of medical resources and facilitate the early detection and intervention of NSSI behaviors in hospitalized adolescents and young adults.


  • Open Access

    Community management: A model that effectively reduces rate of medication discontinuation in patients with schizophrenia

    by Hua Ren, Qin Yang, Changjiu He, Jian Jiao, Zaiquan Dong

    Introduction: Patients with schizophrenia often experience high rates of medication interruptions, which have a range of serious consequences. Previous studies have shown that community management may help to address this situation. Objective: To investigate treatment discontinuation in patients with schizophrenia under community management in China and analyze its associated factors. Methods: The patients were assessed using a self-report questionnaire. The survey content included the following: treatment discontinuation, age, sex, education, residence, marital status, monthly family income, payment method for medication, employment, course of current disease, state of disease, insight, knowledge about drugs, types of drugs received, adverse effects of treatment, accepted follow-up, and family support. Results: A total of 1531 patients with schizophrenia were included. Among them, 63 patients (4.1%) had discontinued medication at some point, while 1468 (95.9%) patients maintained treatment. The two groups showed statistically significant differences in payment methods for medication, state of disease, insight, knowledge about drugs, side effects of drugs, type of drugs received, and status of follow-up visits ( P P <0.05). Conclusion: Patients with schizophrenia under community management had a low rate of treatment discontinuation. The state of the disease, insight, side-effects of drugs, and status of follow-up visits are strongly related to medication interruption.

  • Open Access

    Ethylene oxide exposure, inflammatory indicators, and depressive symptoms: a cross-sectional study and mediation analysis based on a non-institutionalized American population

    by Dongru Du, Yanling Yuan, Xuan Guan, Qinglian Xie, Zaiquan Dong

    Background: Ethylene oxide (EO) is a volatile compound positively correlated with respiratory and cardiovascular diseases. Currently, evidence suggests that environmental exposure may contribute to depressive symptoms. This study evaluated the correlation between EO exposure and depressive symptoms and investigated whether inflammatory indicators had a mediation effect on this correlation.Methods: Patients were enrolled from the National Health and Nutrition Examination Survey during 2013–2016, and 2,764 (49.67% male and 50.33% female) participants were ultimately included. EO exposure was determined by measuring hemoglobin-EO adduct (Hb-EO) concentration due to its long half-life, which was log2-transformed. Depressive symptoms were assessed using the Patient Health Questionnaire-9. Multivariable logistic regression analysis was performed to identify any correlations before and after covariate adjustment. Sensitivity analysis, subgroup analyses, and interaction tests were performed to further evaluate identified correlations. Mediation analysis was conducted to reveal whether specific inflammatory indicators mediated the correlation.Results: A high prevalence of depressive symptoms was observed in quartiles with increased levels of EO exposure, and male individuals exhibiting higher Hb-EO levels than female individuals. A positive correlation was observed between EO exposure and depressive symptoms (odds ratio [OR]: 1.439, 95% confidence interval [CI]: 1.310, 1.581), which remained stable even after covariate adjustment (OR: 1.332, 95% CI: 1.148, 1.545). Interaction tests showed significant effects of sex (p < 0.001) and thyroid diseases (p = 0.048) on this correlation. In the mediation analysis, white blood cell (p = 0.010) and neutrophil counts (p = 0.010) exerted a mediating effect, accounting for 13.6 and 11.9%, respectively.Conclusion: Increased exposure to EO is associated with an elevated risk of depressive symptoms, where white blood cell and neutrophil counts exert a significant mediating effect. Further prospective studies are required to investigate the potential link among EO, other environmental pollutants, and human mental health.


  • Open Access

    Baseline gut microbiota profiles affect treatment response in patients with depression

    by Yingjing Xie, Hanwen Zhu, Yanling Yuan, Xuan Guan, Qinglian Xie, Zaiquan Dong

    The role of the gut microbiota in the pathophysiology of depression has been explored in numerous studies, which have confirmed that the baseline gut microbial profiles of patients with depression differ from those of healthy individuals. The gut microbiome affects metabolic activity in the immune and central nervous systems and regulates intestinal ecology through the neuroendocrine system. Additionally, baseline changes in the gut microbiota differed among patients with depression who demonstrated varying treatment response. Currently, probiotics are an emerging treatment for depression; however, the efficacy of modulating the gut microbiota in the treatment of depression remains uncertain. Additionally, the mechanisms by which changes in the gut microbiota affect treatment response in patients with depression remain unclear. In this review, we aimed to summarize the differences in the baseline gut microbiota between the remission and non-remission groups after antidepressant therapy. Additionally, we summarized the possible mechanisms that may contribute to antidepressant resistance through the effects of the gut microbiome on the immune and nervous systems, various enzymes, bioaccumulation, and blood–brain barrier, and provide a basis for treating depression by targeting the gut microbiota.